BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/3/2023 10:22:43 AM | Browse: 353 | Download: 1118
 |
Received |
|
2023-03-02 14:00 |
|
Peer-Review Started |
|
2023-03-02 14:02 |
|
First Decision by Editorial Office Director |
|
2023-06-12 02:49 |
|
Return for Revision |
|
2023-06-12 02:49 |
|
Revised |
|
2023-07-07 03:22 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-07-17 02:48 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-07-17 07:11 |
|
Articles in Press |
|
2023-07-17 07:11 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-07-27 11:29 |
|
Publish the Manuscript Online |
|
2023-08-03 10:22 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Case Report |
| Article Title |
Anti-phospholipase A2 receptor-associated membranous nephropathy with human immunodeficiency virus infection treated with telitacicept: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jin-Ling Wang, Yan-Ling Sun, Zhe Kang, Sheng-Kun Zhang, Chun-Xin Yu, Wan Zhang, Hong-Li Lin and Hua Xie |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hong-Li Lin, PhD, Chief Physician, Department of Nephrology, The First Affiliated Hospital of Dalian Medical University, No. 222 Zhongshan Road, Dalian 116000, Liaoning Province, China. linhongli1216@163.com |
| Key Words |
Membranous nephropathy; PLA2R; Human immunodeficiency virus; Proteinuria; Telitacicept; Case report |
| Core Tip |
The clinical management of anti-phospholipase A2 receptor-associated membranous nephropathy concurrent with human immunodeficiency virus infection presents significant challenges, primarily due to potential unregulated immune responses. In this report, we demonstrated that a weekly subcutaneous injection of telitacicept (160 mg) could ameliorate the 24-h urinary protein levels and enhance serum albumin concentrations, with no discernible impact on T cell counts, showcasing its safety profile. |
| Publish Date |
2023-08-03 10:22 |
| Citation |
Wang JL, Sun YL, Kang Z, Zhang SK, Yu CX, Zhang W, Lin HL, Xie H. Anti-phospholipase A2 receptor-associated membranous nephropathy with human immunodeficiency virus infection treated with telitacicept: A case report. World J Clin Cases 2023; 5309-5315 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i22/5309.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i22.5309 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
